RDNT · RadNet, Inc.
$70.34
+0.11% last session
End-of-day data · close of 2026-10-23
Market cap
$6B
Enterprise value
$7B
Trailing P/E
—
Forward P/E
79.3
Dividend yield
0.0%
Beta
1.41
Avg volume
1M
Employees
11K
Daily Change %
0.11%
5 Days Change
2.12%
10 Days Change
-1.75%
30 Days Change
-4.03%
60 Days Change
-5.93%
Month to Day Change
3.78%
Year to Day Change
-1.53%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RDNT
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-28
Latest call per bank · past 12 months
Barclays
Overweight$79.00
+12.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-28 | Barclays | Maintains | Overweight | $65.00 → $79.00 |
| 2026-08-11 | Truist Securities | Maintains | Buy | $90.00 → $94.00 |
| 2026-05-20 | Barclays | Maintains | Overweight | $70.00 → $65.00 |
| 2026-04-21 | Barclays | Maintains | Overweight | $86.00 → $70.00 |
| 2026-01-09 | Keybanc | Initiates | Overweight | $0.00 → $92.00 |
| 2025-12-01 | B. Riley Securities | Maintains | Buy | $71.00 → $87.00 |
| 2025-11-13 | Barclays | Maintains | Overweight | $79.00 → $86.00 |
| 2025-11-12 | Truist Securities | Maintains | Buy | $81.00 → $90.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 49 — neutral momentum, neither overbought nor oversold.
- bearish: Price vs 50-day MA: Trading 3.5% below the 50-day MA ($72.85).
- bullish: Price vs 200-day MA: Trading 7.8% above the 200-day MA ($65.22).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.12) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($51.87) and high ($84.48).
RDNT Price Chart
Loading chart for RDNT…
Fundamentals
About RadNet, Inc.
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$249B 17.1% YTD
DHR
Danaher Corporation
$162B 1.0% YTD
NTRA
Natera, Inc.
$58B 75.2% YTD
A
Agilent Technologies, Inc.
$49B 28.7% YTD
IQV
IQVIA Holdings, Inc.
$46B 23.5% YTD
WAT
Waters Corporation
$45B 20.0% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -16.2% YTD
ILMN
Illumina, Inc.
$41B 105.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.